ACTIVE

APOTHEEK PAREDIS-GENK

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result3,6 k €-83,4 %over 1 year
Gross margin160,4 k €-22,6 %over 1 year
Equity197,6 k €+1,8 %over 1 year
Workforce1,8 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK PAREDIS-GENK is a Private limited company incorporated in 2013. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Genk. It employs on average 1,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0543.401.522
Incorporation
12/12/2013
Legal form
Private limited company
Registered office
Bochtlaan 58
3600 Genk · FlandreSee on map
Contributed capital
240 000,00 €
Latest accounts
31/12/2025
Average workforce
1,8 ETP
Joint committees (1)
  • 313
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 11 filings

Trend over 11 financial years

20252024202320222021
Income statement
Gross margin160,4 k €207,1 k €266,5 k €210 k €318,7 k €
EBITDA51,6 k €60,5 k €103,3 k €73,3 k €106,7 k €
Operating result22 k €30,7 k €71,9 k €41,7 k €57,4 k €
Net result3,6 k €21,5 k €56,2 k €27,3 k €72,3 k €
Balance sheet
Equity197,6 k €194 k €172,5 k €116,3 k €89,1 k €
Total assets767,5 k €759,1 k €735,9 k €722,2 k €780,2 k €
Cash21,6 k €3,1 k €10,3 k €18,5 k €8,7 k €
Debts561,9 k €561,3 k €555,1 k €597,5 k €683,2 k €
Other
Workforce1,8 ETP1,8 ETP2,1 ETP2,1 ETP1,7 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 12 ended

Active mandates

LN HERMANAS

Director · since 12 septembre 2024 · 1013.510.537

Represented by Brouns Kristel

Active

Ended mandates

KRIS ESTIEVENART

Director · since 30 août 2016 · until 30 août 2022

Ended
Els Bollen

Director · since 12 décembre 2013

Ended
ELS BOLLEN

Managing director · since 12 décembre 2013 · until 18 décembre 2018

Ended
ELS BOLLEN

Managing director · since 12 décembre 2013 · until 30 août 2022

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/07/202001/07/2019
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202130/06/2020
Length of the financial year12 months12 months12 months12 months18 months12 months
Filing date02/07/202630/06/202520/08/202416/08/202330/08/202201/12/2020
General meeting19/06/202620/06/202521/06/202416/06/202317/06/202227/11/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 11 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202519/06/202602/07/2026DutchPDF
Abridged model31/12/202420/06/202530/06/2025DutchPDF
Abridged model31/12/202321/06/202420/08/2024DutchPDF
Abridged model31/12/202216/06/202316/08/2023DutchPDF
Abridged model31/12/202117/06/202230/08/2022DutchPDF
Abridged model30/06/202027/11/202001/12/2020DutchPDF
Abridged model30/06/201920/12/201923/01/2020DutchPDF
Abridged model30/06/201814/09/201824/10/2018DutchPDF
Abridged model30/06/201715/12/201720/12/2017DutchPDF
Abridged model30/06/201616/12/201621/12/2016DutchPDF
Abridged model30/06/201518/12/201512/01/2016DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 12 ended

Active mandates

LN HERMANAS

Director · since 12 septembre 2024 · 1013.510.537

Represented by Brouns Kristel

Active

Ended mandates

KRIS ESTIEVENART

Director · since 30 août 2016 · until 30 août 2022

Ended
Els Bollen

Director · since 12 décembre 2013

Ended
ELS BOLLEN

Managing director · since 12 décembre 2013 · until 18 décembre 2018

Ended
ELS BOLLEN

Managing director · since 12 décembre 2013 · until 30 août 2022

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates31/10/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other13/10/2020
    ALGEMENE VERGADERING - BOEKJAAR - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM
    PDF
  • Mandates21/10/2016
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other31/12/2013
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20253,6 k €↓
  2. 2024
    Annual accounts 202421,5 k €↓
  3. 2023
    Annual accounts 202356,2 k €↑
  4. 2022
    Annual accounts 202227,3 k €↓
  5. 2021
    Annual accounts 202172,3 k €↑
  6. 2021
    Name changePAREDIS-GENK APOTHEEK
  7. 2020
    Annual accounts 20201,4 k €↓
  8. 2019
    Annual accounts 20195,1 k €↑
  9. 2018
    Annual accounts 2018-7,8 k €↑
  10. 2017
    Annual accounts 2017-73,2 k €↑
  11. 2016
    Annual accounts 2016-73,4 k €↑
  12. 2015
    Annual accounts 2015-75,3 k €
  13. 2015
    Name changeAPOTHEEK PAREDIS-GENK
  14. 12/12/2013
    IncorporationPrivate limited company